Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers

Abstract

We synthesized three peptides, a D-polyarginyl peptide (r8(FITC)), a Tat peptide (Tat(FITC)), and a control peptide (Cp(FITC)) and attached each to amino-CLIO, a nanoparticle 30 nm in diameter. We then examined the effective permeability, Peff, of all six materials through CaCo-2 monolayers. The transport of peptide-nanoparticles was characterized by a lag phase (0-8 h) and a steady-state phase (9-27 h). The steady-state Peff values for peptides were in the order r8(FITC)>Tat(FITC)=Cp(FITC). When r8(FITC) and Tat(FITC) peptides were attached to the nanoparticle, they conferred their propensity to traverse cell monolayers onto the nanoparticle, whereas Cp(FITC) did not. Thus, when the r8(FITC) peptide was attached to the amino-CLIO nanoparticle, the resulting peptide-nanoparticle had a Peff similar to that of this poly-D-arginyl peptide alone. The Peff of r8(FITC)-CLIO (MW approximately 1000 kDa) was similar to that of mannitol (MW=182 Da), a poorly transported reference substance, with a far lower molecular weight. These results are the first to indicate that the modification of nanoparticles by attachment of membrane-translocating sequence-based peptides can alter nanoparticle transport through monolayers. This suggests that the surface modification of nanoparticles might be a general strategy for enhancing the permeability of drugs and that high-permeability nanoparticle-based therapeutics can be useful in selected pharmaceutical applications.

Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and -negative bacterial strains

“…29 Another proposed way in which the membrane can be compromised is the alteration of membrane lipid components. 30 It is, however, difficult to distinguish between the bactericidal activity of nanoparticles from the ions released by the nanoparticles themselves. 31 Previously, Ruparelia et al estimated the concentration of released ions for 10 mg of copper nanoparticles suspended in 100 mL nutrient media and distilled water.…”

“…The extent of inhibition of bacterial growth observed in this study was found to be variable and size-dependant. The smallest CuO nanoparticles (particle size 20 ± 1.24 nm) synthesized at the lowest Particle size (nm) Particle size (nm) 30 31…”

Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures

“…In drug delivery application, the critical step is the transport across cell layers (Koch et al, 2005) and the internalization of nanoparticles into specific cells, a process often limited by poor targeting specificity and low internalization efficiency of therapeutic ligands grafted on the nanoparticles. A number of studies have addressed the cell-surface binding or cell uptake of functionalized SPIONs.…”

Gold nanoparticles in cancer therapy

“…Following cellular uptake, AuNPs are stored in endosomal/lysosomal vesicles. In order to liberate these AuNPs and introduce the drug which has been delivered into the cell cytoplasm, the NPs need to be modified by the conjugation of membranetranslocating sequence-based peptides which enable them to traverse monolayers [51] . Tumor necrosis factor-alpha (TNF-α) is a potent, multifunctional cytokine which not only plays a critical role in inflammation and immunity, but also exhibits anticancer properties [52] .…”